Based on recent data, Sangamo Therapeutics, Inc. (SGMO) shows an Average True Range (ATR) of 0.05 and an Enterprise Value of 93.31M. Its average trading volume over the past 3 months is 6.79M, indicating liquidity. These fundamental metrics provide insight into SGMO's underlying financial health and market activity.
| ATR | 0.05 |
| Enterprise Value | 93.31M |
| Avg Vol (3 Months) | 6.79M |
| Avg Vol (10 Days) | 606.48K |
Sangamo Therapeutics, Inc. (SGMO) technical indicators as of June 23, 2026: the SMA 20 is 5.53%, SMA 50 at 4.56%, and SMA 200 at -13.08%. The RSI 14 value is 54.1, suggesting its current momentum. These technical analysis signals help assess SGMO's price trends and potential future movements.
| SMA 20 | 5.53% |
| SMA 50 | 4.56% |
| SMA 200 | -13.08% |
| RSI 14 | 54.1 |
Sangamo Therapeutics, Inc. (SGMO) stock performance overview as of June 23, 2026: The 52-week high is $0.766 (currently -58.49% below), and the 52-week low is $0.1 (currently 27.54% above). Over the past year, SGMO's performance is -66.73%, compared to the S&P 500's 10.67% change.
| 52-Week High | 0.766 |
| 52-Week High Chg | -58.49% |
| 52-Week Low | 0.1 |
| 52-Week Low Chg | +27.54% |
| S&P 500 52-Week Chg | 10.67% |
According to market data, Sangamo Therapeutics, Inc. (SGMO) stock's recent performance metrics show that over the last month, SGMO is -16.48%, with a Year-to-Date (YTD) performance of -12.86%. Over the past year, the stock has seen a -66.73% change. These figures summarize SGMO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.1918 | 0.2525 | 0.4145 | 0.6 | 0.766 | 0.6 |
| Low | 0.1515 | 0.1312 | 0.1 | 0.1 | 0.1 | 0.1 |
| Performance | -18.49% | -16.48% | -42.75% | -26.00% | -66.73% | -12.86% |
According to current financial data, SGMO stock's P/E (TTM) ratio is -0.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for SGMO, including P/S (2.14), P/B (-3.67), and P/FCF (-0.82), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SGMO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.47 | -1.22 | -5.02 | 32.59 |
| P/S (TTM) | 2.14 | 3.69 | 462.04 | 5.98 |
| P/B (TTM) | -3.67 | 1.72 | 12.18 | 5 |
| P/FCF (TTM) | -0.82 | 45.13 | -908.56 | 28.32 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep